Companies: 10,795·Total market cap: $144.5T
InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

INMNASDAQHealthcare● Active
$1.54
$-0.04(-2.53%)
Market Cap$2787286
P/E Ratio
52W High$5.5
52W Low$0.575

InMed Pharmaceuticals Inc.(INM)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · INM · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$4.94M$4.60M$4.14M$1.09M$0.00M
Cost of Revenue$3.24M$3.50M$2.73M$0.55M$0.00M
Gross Profit$1.71M$1.10M$1.40M$0.54M$0.00M
Gross Margin %(computed)34.53%23.94%33.93%49.89%
Operating Expenses
R&D Expenses$2.85M$3.22M$3.73M$7.28M$6.62M
G&A Expenses$6.56M$5.80M$5.85M$6.87M$5.55M
Total Operating Expenses$9.62M$9.24M$9.78M$14.34M$12.17M
Operating Income($7.92M)($8.13M)($8.38M)($13.79M)($12.17M)
Operating Margin %(computed)-160.20%-176.92%-202.60%
Interest Income$0.16M$0.72M$0.65M$0.12M$0.02M
Interest Expense$0.37M$0.00M$0.00M$0.00M$0.36M
Income Before Tax($8.16M)($7.67M)($7.93M)($18.60M)($12.65M)
Income Tax Expense$0.00M$0.01M$0.01M$0.00M$0.00M
Net Income($8.16M)($7.68M)($7.95M)($18.60M)($12.65M)
Net Margin %(computed)-165.14%-166.94%-192.18%
Per Share & EBITDA
EPS (Basic)$-8.36$-20.14$-64.92$-16582.00$-938.91
Wtd Avg Shares0.98M0.38M0.12M0.00M0.01M
EBITDA($7.26M)($7.06M)($7.78M)($13.28M)($12.17M)
EBITDA Margin %(computed)-146.80%-153.64%-188.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解InMed Pharmaceuticals Inc.

关于InMed Pharmaceuticals Inc.(INM)损益表

InMed Pharmaceuticals Inc.(INM)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,INM实现营收$0.00B,毛利润$0.00B(毛利率34.53%),净利润($0.01B)(净利率-165.14%)。

常见问题

INM · 4 问

InMed Pharmaceuticals Inc.(INM)2025财年营收为$0.00B,同比up7.5%。

INM revenueINM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09